Finance

Lists
Why is 003017 down 2,12%?
Dive Deeper
003017:SHE
Zhejiang Dayang Biotech Group Co Ltd
CN¥22,20
-2,12%
(-0,48) 1D
12 Okt., 12:13:30 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003017...
Open
CN¥22,70
High
CN¥22,75
Low
CN¥22,09
Mkt. cap
2,29 mjd
Avg. vol.
1,59 m
Volume
1,12 m
Dividend
2,48%
Quarterly dividend
CN¥0,14
Ex-dividend date
26 Jun. 2026
P/E ratio
20,59
52-wk high
CN¥30,82
52-wk low
CN¥18,82
EPS
CN¥1,08
Shares outstanding
100,80 m
No. of employees
771
Open
CN¥22,70
High
CN¥22,75
Low
CN¥22,09
Mkt. cap
2,29 mjd
Avg. vol.
1,59 m
Volume
1,12 m
Dividend
2,48%
Quarterly dividend
CN¥0,14
Ex-dividend date
26 Jun. 2026
P/E ratio
20,59
52-wk high
CN¥30,82
52-wk low
CN¥18,82
EPS
CN¥1,08
Shares outstanding
100,80 m
No. of employees
771
News stories
From web sources and news partners
About Zhejiang Dayang Biotech Group Co Ltd
CEO-
Employees771
Founded01 Jan. 1976
Headquarters-
SectorSpeciality chemicals
Websitedyhg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
248,00 m
298,13 m
278,13 m
280,76 m
Cost of goods sold
190,70 m
238,70 m
212,88 m
219,27 m
Cost of revenue
190,70 m
238,70 m
212,88 m
219,27 m
Research and development expenses
10,42 m
16,08 m
9,06 m
14,69 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,90 m
19,40 m
23,53 m
23,25 m
Operating expense
23,33 m
43,58 m
30,34 m
37,07 m
Total operating expenses
214,02 m
282,28 m
243,22 m
256,34 m
Operating income
33,97 m
15,85 m
34,90 m
24,43 m
Other non operating income
-468,53 k
147,23 k
-1,34 m
1,02 m
EBT including unusual items
27,44 m
24,77 m
34,76 m
28,55 m
EBT excluding unusual items
34,44 m
18,83 m
35,18 m
24,71 m
Income tax expense
-1,92 m
4,37 m
3,86 m
2,53 m
Effective tax rate
-7,00%
17,62%
11,09%
8,87%
Other operating expenses
-8,84 m
7,19 m
-4,28 m
659,38 k
Net income
29,53 m
19,82 m
30,87 m
26,60 m
Net profit margin
11,91%
6,65%
11,10%
9,47%
Earnings per share
-
-
-
-
Interest and investment income
2,37 m
3,66 m
2,41 m
2,33 m
Interest expense
-940,75 k
-919,14 k
-785,64 k
-882,93 k
Net interest expenses
1,43 m
2,74 m
1,62 m
1,45 m
Depreciation and amortization charges
-
-
-
-
EBITDA
50,83 m
33,69 m
52,73 m
42,22 m
Gain or loss from assets sale
-
-2,05 m
-
21,12 k
AI content may include mistakes. Learn more
Google-programme